miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma

Abstract Background Ovarian cancer is the second most common gynecologic cancer with high mortality rate and generally diagnosed in advanced stages. The 5-year disease-free survival is below 40%. MicroRNAs, subset of the non-coding RNA molecules, regulate the translation in post transcriptional leve...

Full description

Bibliographic Details
Main Authors: Seref Bugra Tuncer, Ozge Sukruoglu Erdogan, Seda Kilic Erciyas, Mukaddes Avsar Saral, Betul Celik, Demet Akdeniz Odemis, Gozde Kuru Turkcan, Hulya Yazici
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Journal of Ovarian Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13048-020-00706-8
id doaj-25ad4afd2c434cb9863a10810f036501
record_format Article
spelling doaj-25ad4afd2c434cb9863a10810f0365012020-11-25T03:38:20ZengBMCJournal of Ovarian Research1757-22152020-08-0113111510.1186/s13048-020-00706-8miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinomaSeref Bugra Tuncer0Ozge Sukruoglu Erdogan1Seda Kilic Erciyas2Mukaddes Avsar Saral3Betul Celik4Demet Akdeniz Odemis5Gozde Kuru Turkcan6Hulya Yazici7Department of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityDepartment of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityDepartment of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityDepartment of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityDepartment of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityDepartment of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityDepartment of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityDepartment of Cancer Genetics, Istanbul Faculty of Medicine, Oncology Institute, Istanbul UniversityAbstract Background Ovarian cancer is the second most common gynecologic cancer with high mortality rate and generally diagnosed in advanced stages. The 5-year disease-free survival is below 40%. MicroRNAs, subset of the non-coding RNA molecules, regulate the translation in post transcriptional level by binding to specific mRNAs to promote or degrade the target oncogenes or tumor suppressor genes. Abnormal expression of miRNAs were found in numerous human cancer, including ovarian cancer. Investigating the miRNAs derived from the peripheral blood samples can be used as a marker in the diagnose, treatment and prognosis of ovarian cancer. We aimed to find biological markers for early diagnosis of ovarian cancer by investigating BRCA1 gene mutation carrier monozygotic discordant twins and their high risk healthy family individual’s miRNAs. Methods The study was conducted on monozygotic twins discordant for ovarian cancer, and the liquid biopsy exploration of miRNAs was performed on mononuclear cells that were isolated from the peripheral blood samples. The miRNA expression profile changes in the study were found by using microarray analysis. miRNA isolation procedure performed from the lymphocyte in accordance with the kit protocol. The presence and quality of the isolated miRNAs screened by electrophoresis. Raw data logarithmic analysis was studied by identifying the threshold, normalization, correlation, mean and median values. Target proteins were detected for each miRNA by using different algorithms. Results After the comparison of monozygotic discordant twins for epithelial ovarian carcinoma upregulation of the 4 miRNAs, miR-6131, miR-1305, miR-197-3p, miR-3651 and downregulation of 4 miRNAs, miR-3135b, miR-4430, miR-664b-5p, miR-766-3p were found statically significant. Conclusions The detected 99 miRNAs out of 2549 miRNAs might be used in the clinic as new biological indicators in the diagnosis and follow up of epithelial ovarian cancer with complementary studies. The miRNA expression profiles were identified to be statistically significant in the evaluation of ovarian cancer etiology, BRCA1 mutation status, and ovarian cancer risk in accordance with the obtained data. There is a need for validation of the miRNAs which were particularly detected between monozygotic twins and its association with ovarian cancer was emphasized in our study in wider cohorts including ovarian cancer patients, and healthy individuals.http://link.springer.com/article/10.1186/s13048-020-00706-8Monozygotic twinsmiRNA expression profilesBRCA1 and BRCA2Biomarkers
collection DOAJ
language English
format Article
sources DOAJ
author Seref Bugra Tuncer
Ozge Sukruoglu Erdogan
Seda Kilic Erciyas
Mukaddes Avsar Saral
Betul Celik
Demet Akdeniz Odemis
Gozde Kuru Turkcan
Hulya Yazici
spellingShingle Seref Bugra Tuncer
Ozge Sukruoglu Erdogan
Seda Kilic Erciyas
Mukaddes Avsar Saral
Betul Celik
Demet Akdeniz Odemis
Gozde Kuru Turkcan
Hulya Yazici
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
Journal of Ovarian Research
Monozygotic twins
miRNA expression profiles
BRCA1 and BRCA2
Biomarkers
author_facet Seref Bugra Tuncer
Ozge Sukruoglu Erdogan
Seda Kilic Erciyas
Mukaddes Avsar Saral
Betul Celik
Demet Akdeniz Odemis
Gozde Kuru Turkcan
Hulya Yazici
author_sort Seref Bugra Tuncer
title miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
title_short miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
title_full miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
title_fullStr miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
title_full_unstemmed miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
title_sort mirna expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
publisher BMC
series Journal of Ovarian Research
issn 1757-2215
publishDate 2020-08-01
description Abstract Background Ovarian cancer is the second most common gynecologic cancer with high mortality rate and generally diagnosed in advanced stages. The 5-year disease-free survival is below 40%. MicroRNAs, subset of the non-coding RNA molecules, regulate the translation in post transcriptional level by binding to specific mRNAs to promote or degrade the target oncogenes or tumor suppressor genes. Abnormal expression of miRNAs were found in numerous human cancer, including ovarian cancer. Investigating the miRNAs derived from the peripheral blood samples can be used as a marker in the diagnose, treatment and prognosis of ovarian cancer. We aimed to find biological markers for early diagnosis of ovarian cancer by investigating BRCA1 gene mutation carrier monozygotic discordant twins and their high risk healthy family individual’s miRNAs. Methods The study was conducted on monozygotic twins discordant for ovarian cancer, and the liquid biopsy exploration of miRNAs was performed on mononuclear cells that were isolated from the peripheral blood samples. The miRNA expression profile changes in the study were found by using microarray analysis. miRNA isolation procedure performed from the lymphocyte in accordance with the kit protocol. The presence and quality of the isolated miRNAs screened by electrophoresis. Raw data logarithmic analysis was studied by identifying the threshold, normalization, correlation, mean and median values. Target proteins were detected for each miRNA by using different algorithms. Results After the comparison of monozygotic discordant twins for epithelial ovarian carcinoma upregulation of the 4 miRNAs, miR-6131, miR-1305, miR-197-3p, miR-3651 and downregulation of 4 miRNAs, miR-3135b, miR-4430, miR-664b-5p, miR-766-3p were found statically significant. Conclusions The detected 99 miRNAs out of 2549 miRNAs might be used in the clinic as new biological indicators in the diagnosis and follow up of epithelial ovarian cancer with complementary studies. The miRNA expression profiles were identified to be statistically significant in the evaluation of ovarian cancer etiology, BRCA1 mutation status, and ovarian cancer risk in accordance with the obtained data. There is a need for validation of the miRNAs which were particularly detected between monozygotic twins and its association with ovarian cancer was emphasized in our study in wider cohorts including ovarian cancer patients, and healthy individuals.
topic Monozygotic twins
miRNA expression profiles
BRCA1 and BRCA2
Biomarkers
url http://link.springer.com/article/10.1186/s13048-020-00706-8
work_keys_str_mv AT serefbugratuncer mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
AT ozgesukruogluerdogan mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
AT sedakilicerciyas mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
AT mukaddesavsarsaral mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
AT betulcelik mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
AT demetakdenizodemis mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
AT gozdekuruturkcan mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
AT hulyayazici mirnaexpressionprofilechangesintheperipheralbloodofmonozygoticdiscordanttwinsforepithelialovariancarcinomapotentialnewbiomarkersforearlydiagnosisandprognosisofovariancarcinoma
_version_ 1724542737014849536